ArticleMagnetic resonance imaging2026
Self-enhancement-based perfusion mapping with contrast-enhanced magnetic resonance imaging for PAD assessment.
Article in Magnetic resonance imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
We developed an automatic self-enhancement-based perfusion mapping (SEPM) method to relatively map the microvascular perfusion level in contrast-enhanced magnetic resonance imaging (CE-MRI) into four categories: hyper-enhanced, isoenhanced, hypo-enhanced, and non-enhanced. These regions are identified based on the relative enhancement from the local pre-contrast arrival frame. We hypothesized that the signal intensity and change in signal intensity of skeletal calf muscles over a course of approximately 10 min of dynamic CE-MRI are measures of perfusion abnormalities that are of importance in patients with peripheral artery disease (PAD). Impairments of the microvascular circulation of the skeletal calf muscles in PAD patients can be quantified by analyzing signal enhancement patterns in CE-MRI. We assessed hypoperfusion in 52 study participants including 35 PAD patients and 17 matched controls. We also investigated PAD subgroups with a known higher risk of adverse outcomes including those with concomitant diabetes mellitus and those who did not complete a graded 6-min treadmill walking test. Our findings show that PAD patients demonstrate a consistently higher rate of hypoperfusion percentages compared to matched controls. Our findings further indicate that each calf muscle group exhibits varying levels of heterogeneity, reflecting non-uniform perfusion dynamics. In five distinct calf muscle groups and averaged over all calf muscle compartments, the average percentage of the hypoperfused regions was lowest in the control group and highest in the more severe PAD groups including treadmill non-completers and those with concomitant diabetes. The quantification of the microcirculation is of importance to assess PAD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.